Publications

Truax JF, Choksi NY, Inhof CJ, Allen DG, Tice RR, Stokes WS. Validation status of the Isolated Rabbit Eye (IRE) test method. Poster presented at Society of Toxicology 44th Annual Meeting, New Orleans, LA, March 2005

Allen DG, Choksi NY, Inhof CJ, Truax JF, Tice RR, Stokes WS. Validation status of the Isolated Chicken Eye (ICE) test method. Poster presented at Society of Toxicology 44th Annual Meeting, New Orleans, LA, March 2005.

Inhof CJ, Choksi NY, Allen DG, Truax JF, Tice RR, Stokes WS. Validation status of the Bovine Corneal Opacity and Permeability (BCOP) test method. Poster presented at Society of Toxicology 44th Annual Meeting, New Orleans, LA, March 2005.

Choksi NY, Allen DG, Inhof CJ, Truax JF, Tice RR, Stokes WS. Validation status of the Hen’s Egg Test-Chorioallantoic Membrane (HET-CAM) test method. Poster presented at Society of Toxicology 44th Annual Meeting, New Orleans, LA, March 2005.

Choksi NY, Allen DG, Inhof CJ, Truax JF, Tice RR, Stokes WS. Performance of BCOP, IRE, ICE, and HET-CAM in detecting substances that induce severe irritation and irreversible ocular damage. Presented at Society of Toxicology 44th Annual Meeting, New Orleans, LA, March 2005.

Haseman JH, Choksi NY, Inhof CJ, Truax JF, Tice RR, Stokes WS. The performance characteristics of the in vivo rabbit eye test. Poster presented at Society of Toxicology 44th Annual Meeting, New Orleans, LA, March 2005

Teeguarden JG, Waechter JM Jr, Clewell HJ 3rd, Covington TR, Barton HA. 2005. Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding and uterine tissue dose metrics of bisphenol A: A physiologically based pharmacokinetic approach. Toxicol Sci 85:429–446.

Staskal DF, Diliberto JJ, DeVito MJ, Birnbaum LS. 2005. Inhibition of human and rat CYP1A2 by TCDD and dioxin-like chemicals. Toxicol Sci 84(2):225-31; doi: 10.1093/toxsci/kfi090.

Staskal DF, Diliberto JJ, DeVito MJ, Birnbaum LS. 2005. Toxicokinetics of BDE 47 in female mice: Effects of dose, route of exposure, and time. Toxicol Sci. 83(2):215-23; doi: 10.1093/toxsci/kfi018.

Urban JD, Mailman RB. Characterization of the N27 dopaminergic cell line as a model for elucidating the actions of functionally selective dopaminergic ligands. 35th Annual Neuroscience Meeting, Washington, DC, November 2005.

Grasty RC, Roberts N, Klinefelter G, Bjork JA, Wallace KB, Lau CS, Rogers JM. 2005. Effects of prenatal perfluorooctanesulfonate (PFOS) exposure on lung maturation in the perinatal rat. Birth Defects Res A 73: 314.

Connor K, Harris M, Edwards M, Chu A, Clark G, Finley B. Estimating the total TEQ in human blood from naturally-occurring vs. anthropogenic dioxins: A dietary study. Dioxin 2004, Berlin, Germany, 2004.

Haws, L. Roundtable: Is it time to reevaluate the toxic equivalency factors for PCDDs, PCDFs, and dioxin-like PCBs? The use of toxicity equivalence factors (TEFs) for PCDDs, PCDFs, and dioxin-like PCBs in risk assessment: Improving the process. Dioxin 2004. September Berlin, Germany, September 2004.

Proctor DM, Panko JP, Liebig EW, Paustenbach, DJ. 2004. Estimating historical occupational exposure to airborne hexavalent chromium in a chromate production plant: 1940–1972. J Occup Environ Hyg. 1(11):752–767; doi: 10.1080/15459620490523294.

Haws L, Harris M, Su S, Birnbaum L, DeVito M, Farland W, Walker N, Connor K, Santamaria A, Finley B. Development of a refined database of relative potency estimates to facilitate better characterization of variability and uncertainty in the current mammalian TEFs for PCDDs, PDCFs, and dioxin-like PCBs. Dioxin 2004, Berlin, Germany, 2004.

Schecter, A, Papke O, Tung KC, Staskal DF, Birnbaum L. 2004. Polybrominated diphenyl ether contamination of United States food. Environ Sci Technol 38(20):5306-5311; doi: 10.1021/es0490830.

Haws L, Harris M, Su S, Walker N, Birnbaum L, DeVito M, Farland W, Connor K, Santamaria A, Finley B. A preliminary approach to characterizing variability and uncertainty in the mammalian PCDD/F and PCB TEFs. Dioxin 2004, Berlin, Germany, 2004.

Thompson CM, Wojno H, Greiner E, May EL, Rice KC, Selley DE. 2004. Activation of G-proteins by morphine and codeine congeners: Insights to the relevance of O- and N-demethylated metabolites at μ- and δ-opioid receptors. J Pharmacol Exper Therapeut 308(2):547–554; PMID: 14600248.

Perry CS, Morton E. Lessons learned from creating integrated Excel models to calculate human health screening values. Society for Risk Analysis Annual Meeting, Palm Springs, CA, December 2004.

Warren DA, Kerger BD, Britt JK, James RC. 2004. Development of an oral cancer slope factor for Aroclor 1268. Regul Toxicol Pharmacol 40(1):42-53; doi: 10.1016/j.yrtph.2004.04.005.